Sacubitril/Valsartan (LCZ696): A Novel Treatment for Heart Failure and its Estimated Cost Effectiveness, Budget Impact, and Disease Burden Reduction in Germany.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2018 AND VI 36 AND IP 10
Results: 11
1
2
Comment on: Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial.
- Published in:
- 2018
- By:
- Publication type:
- Letter
3
Modeling Approaches in Cost-Effectiveness Analysis of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: An Updated Systematic Review and Recommendations for Future Economic Evaluations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
4
Using Evidence from Randomised Controlled Trials in Economic Models: What Information is Relevant and is There a Minimum Amount of Sample Data Required to Make Decisions?
- Published in:
- 2018
- By:
- Publication type:
- journal article
5
Costs of Invasive Meningococcal Disease: A Global Systematic Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
6
Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
7
The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
8
Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
9
Cost Effectiveness of Pharmacological Treatments for Asthma: A Systematic Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
10
Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
11
Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article